Search
ChatPaper
AI Writing
analysis
Analysis
编组
Open Data
more
More
RankingsMust ReadingJournal&ConferenceAI TRAI HistoryMaster Reading TreeXiaomai's Star TalentsTrajectoryTalentNDI TrackerAI sign LanguageOpen
VIPCreated with Sketch.

A novel fusion protein consisting of anti-ANGPTL3 antibody and interleukin-22 ameliorates diabetic nephropathy in mice.

Qianqian Ma,Xiaozhi Hu,Fangyu Liu,Zhonglian Cao,Lei Han,Kaicheng Zhou,Yu Bai,Yuting Zhang,Yanyang Nan,Qianying Lv,Jia Rao,Tao Wu,Xue Yang,Haidong He,Dianwen Ju,Hong Xu

Frontiers in immunology（2022）

Cited 1|Views4
No score
Abstract
Collectively, anti-ANGPTL3/IL22 bifunctional fusion protein can be a promising novel therapeutic strategy for DN by reducing podocyte injury, ameliorating inflammatory response, and enhancing renal tissue recovery.
More
Translated text
Key words
angiopoietin-like protein 3,diabetic nephropathy,diabetic nephropathy DN,fusion protein,inflammatory response,interleukin-22,podocyte injury
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined